45th DIA Annual Meeting Series
DIA Annual Meeting
Nancy D. Smith, PhD, former director, office of training and communications, CDER, FDA, discusses this year's meeting theme, "Better Medicines: Improving Safety with Every Step," and the CDER Town Meeting that has become a DIA staple.
Felix Gyi, PharmD, MBA, CEO of Chesapeake Research Review discusses ethical rewards for patients in clinical studies and how the relationships between pharma and health care professionals affects subject recruitment and retention.
How has the role of Regulatory Affairs evolved? Armed with results from a Tufts CSDD 2008/2009 study, Kenneth Getz, MBA, explains how, providing a vivid analysis of the expectations, responsibilities, and required skills of today´s Regulatory Affairs professional.
Newsletter
Stay current in clinical research with Applied Clinical Trials, providing expert insights, regulatory updates, and practical strategies for successful clinical trial design and execution.
Related Articles
- Behind the Buzz: Why Clinical Research Leaders Flock to SCOPE Summit
February 7th 2025
- The MDR: Navigating Europe’s New Standard for Medical Device Safety
October 25th 2022